View Article

  • Analytical Method Development for Assay of Omeprazole in Bulk and Pharmaceutical preparations
  • Department of Chemistry, K.V.R. Government College for Woman (A), Kurnool, AP, India

Abstract

A simple, rapid and accurate spectrophotometric method was developed for the determination of omeprazole in pure form and pharmaceutical formulations. The charge-transfer interaction between omeprazole as electron and 2,3-dichloro-5,6-dicyano-p-benzoquinone as pi-electron In the present study omeprazole reated with 2, 3-dichloro-5, 6-dicyano-1, 4-benzquinone to form an orange red colour charge–transfer complex which has maximum absorption at 460 nm against reagent blank.Beer's law is obeyed in the concentration range of 20-100 ?g/ml. The proposed method was precise, accurate and reproducible and it was extended to the analysis of terazosin in the tablet formulations.

Keywords

Omeprazole, 2, 3-dichloro-5, 6-dicyano-1, 4-benzquinone, Spectrophotometer

Introduction

Omeprazole (Fig.1) is chemically5-methoxy-2-[[(4-methoxy-3, 5-dimethylpyridinyl) methyl]Sulfinyl]-1H-benzimidazole, a substituted benzimidazole that inhibits gastric secretion by altering the activity of H+ /K+ ATPase, which is the final common step of acid secretion in parietal cells2 . It is employed in treatment of peptic ulcers, reflux esophagitis and Zollinzers Ellison syndrome3-5. Omeprazole is a white to off-white crystalline powder that melts with decomposition at about 155°C. It is a weak base, freely soluble in ethanol and methanol, and slightly soluble in acetone and isopropanol and very slightly soluble in water. The stability of omeprazole is a function of pH; it is rapidly degraded in acid media, but has acceptable stability under alkaline conditions. Its empirical formula is C17H19N3O3S, with a molecular weight of 345.42. Literature survey reveals different analytical techniques for the determination of omeprazole which includes Spectrophotometric method1-13, HPLC method14-16, Spectrofluorimetric method17, RPHPLC method18-19, HPTLC Method20, Capillary electrophoresis21 Glassy carbon electrode22,  Polarographic method23, Fluorometric Method24, Spectrophotometric and chromatographic method25, HPLC-UV method26. The aim of present study is to estimate a simple, reliable, accurate, precise, and cost effective spectrophotometric method for estimation of omeprazole in its dosage and pharmaceutical formulations.

 


       
            Omeprazole.png
       

    

Fig.1. Omeprazole

 

DETECTION OF WAVELENGTH FOR OMEPRAZOLE

The detection wavelength was determined by scanning the orange red solution in the range 400-630 nm using reagent blank. The overlain spectra were scanned and the wavelength was detected as 460 nm which was selected for analysis see figure 2.


       
            Spectrum of omeprazole treated DDQ solutions.png
       

    

Fig.2: Spectrum of omeprazole treated DDQ solutions

MATERIALS AND METHODS

Instrumentation

Spectronic 1000 plus UV Visible Spectrophotometer with 1 cm matched quartz cells was used for all spectral and absorbance measurements.

Reagents

All the chemicals and reagents used were of analytical grade and solutions were prepared in double distilled water. AR grade methanol was used in the present study.

DDQ  solution(1% w/v): 2,3-dichloro 5,6-dicyano-p-benzoquinone (Loba Chem., India) solution is prepared by dissolving 100 mg in 100 ml of distilled water.

Preparation of standard omeprazole solution: 50 mg of pure dissolved in methanol and the volume is adjusted to 50 ml with methanol. The stock solution is further diluted to get working concentration of 100 mg /mL.

Assay Procedure:

Various aliquots of the standard omeprazole solution ranging from 0.2-1.0 ml were transferred into a series of standard flasks. To each flask, 1.0 ml of 2, 3-dichloro-5, 6-dicyano-1, 4-benzquinon ewas added to produce an orange red colour. The final volume was brought to 10 ml with methanol. The reaction mixture in each flask was well shaken and allowed to stand for 5 min to complete the reaction. The absorbance of the orange red colour solution was measured at 450 nm, against the reagent blank prepared in similar manner omitting drug solution. Calibration graph is obtained by plotting absorbance values against the concentration of omeprazole solution. The calibration curve was found to be linear over a concentration range of 20 to 100 ?g/ml of omeprazole. The amount of omeprazole present in the sample was read from the calibration graph(fig.2).


       
            Calibration curve of omeprazole.png
       

    

Fig.3: Calibration curve of omeprazole

Pharmaceutical formulations

Tablets are weighed and contents are powdered and well mixed. The powder equivalent to 50 mg of omeprazole dissolved in methanol, filtered, residue is washed with distilled water and the volume is made upto 50 ml with methanol. Further dilution is made as described in the preparation of standard solution of omeprazole. Further analysis is carried out as per procedure described above and results are summarized in the Table.2. The amount of drug present in the sample is estimated from calibration graph.

Validation of Proposed Method

Linearity: Validation was performed according to ICH guidelines. The linearity of the produced coloured product was investigated in the range of 20-100 µg/ml of  omeprazole. Correlation coefficient found was 0.9994 which indicates that the proposed method was suitable for the quantitative analysis.

Precision

Precision of the method was studied by repeated measurements of drug solution and results showed lower %RSD values. The % RSD was calculated and was found to be in good terms with < 2>

RESULTS AND DISCUSSIONS

In the present study the omeprazole react with 2, 3-dichloro-5, 6-dicyano-1, 4-benzquinonesolution to form an orange red charge complex. The orange red coloured charge complex solution formed was measured at 460 nm against reagent blank. The amount of drug read from calibration curve. The calibration curve was linear over the range of 20-100 ?g/ml of omeprazole. The optical characteristics of the proposed method such as absorption maxima, Beer´s law limits, molar absorptivity and Sandell´s sensitivity are presented in Table 1. The molar absorp¬tivity and Sandell´s sensitivity values show sensitivity of the method. The regression analysis using method of least squares was made for the slope (b), intercept (a) and correlation (r) obtained from different concentrations and results are summarized in the Table 1. The value of correlation coefficient (r) was 0.9994, which indicated the good linearity of calibration lines. The percent relative standard deviation calculated from the five measurements of terazosin hydrochloride shown in Table 1.  The % RSD is less than 2, which indicates that the method has good reproducibility. The values of standard deviation values are low, indicates high accuracy and reproducibility of the method. The ‘t’ calculated values are compares well with the theoretical value of 2.78 there by indicating that the precision of the method. The assay and validation results are satisfactory therefore the developed method can used for routine analysis of formulations without interference from excipients.

CONCLUSION

The proposed method is found to be simple, precise, accurate and time saving, reproducible and can be conveniently adopted for routine analysis of estimation of omeprazole in bulk drugs samples and pharmaceutical formulations.

 

Optical characteristics of the proposed methods

Table.1 Optical characteristics of the proposed methods


       
            Optical characteristics of the proposed methods.png
       

    

*Y = a+bx, where Y is the absorbance and x concentration in ?g/ml         

Table No: 2 Assay of omeprazole in tablet formulations


       
            2 Assay of omeprazole in tablet formulations.png
       

    

*Average of five determination based on label claim

 

REFERENCE

  1. Karljikovic-Rajic K, Novovic D, Marinkovic V, Agbaba D.First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities..J Pharm Biomed Anal. 2003: 8(4-5);1019-27.
  2. Wahbi AA, Abdel-Razak O, Gazy AA, Mahgoub H, Moneeb MS. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations..J Pharm Biomed Anal. 2002:30(4);1133-42.
  3. Bhandage A, Bhosale A, Kasture A, Godse VP, Trop P, J. Extractive Spectrophotometric Determination of Omeprazole in Pharmaceutical. J Chem Pharm Bull (Tokyo) 2009:8(5);449-54
  4. Ashraf M. Mahmoud, New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms Int J Anal Chem, 2009: 1-11.
  5. Lotfy HM, Abdel-Monem Hagazy M. Comparative study of novel spectrophotometric methods manipulating ratio spectra:an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochimica acta Part A, Molecular and biomolecular spectroscopy 2012:96;259-70.
  6. Shakeel Ahmed, Santosh R. Karajgi, CC. Simpi, Savita sonawane, N.V.Kalyane. Visible spectrophotometric method for the estimation of losartan and omeprazole in single component pharmaceutical formulations. International Journal of PharmTech Research. 2009:1(4), 1247-1250.
  7. Mehdi Ansari, “Development and validation of kinetic spectrophotometric method for the determination of losartan potassium in pure and commercial tablets”, IJPT. 2004; 3: 21-25.
  8. Sashy C, Naidu P, murthy S, Spectrophotometric method for estimation of omeprazole, Indian journal pharm Sci, 2007; 69: 318-20 5. Muran Ozaltin & Aysegul Kocer, Determination of omeprazole in pharmaceuticals by derivative spectroscopy,journal of pharmaceutical and biomedical analysis, 1997;16(2): 337-342 6.
  9. Salama F, Abasaway. E, Validation of the spectrophometric determination of omeprazole & pantoprazole sodium via their metal chelates,journal of pharmaceutical & bio medical analysis, 2003; 33: 411-421.
  10. Abdel– Aziz M., Mayma.A, Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations, 2002; 30: 1133 – 1142.
  11. Sanker D.G,“Extractive spectrophotometric determination of losartan Potassium using acidic and basic dyes”, Indian drugs, 2003; 40: 724- 726. 3.
  12. Panel Abdel-Aziz, M Wahbi, Omayma Abdel-Razak, Azza A Gazy,             Hoda Mahgoub, Marwa S Moneeb. Spectrophotometric determination of omeprazole,lansoprazole and pantoprazole in pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis,2002: 30(4) 1133-1142.
  13. Harrizul Rivai, Rizqa Hasanah, Zikra Azizah Recent Development and Validation of Omeprazole Analysis Methods in Capsules with Absorbance Methods and Areas under Curves Methods with UV- Vis Spectrophotometry. Technological Innovation in Pharmaceutical Research. 2021: 3-35-47

 

  1. Nevin Erk, Analysis of binary mixture of losartan and hydrochlorothize by using high performance liquid chromatography, ratio derivative spectrophotometric and compecsation technique , J. Pharm. Biomed anal., 2001; 24: 603-611.
  2. El-Sherif ZA, Mohamed AO, ElBardicy MG, El-Tarras MF. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. J Chem Pharm Bull (Tokyo) 2006;54(6):814-8.
  3. Noubarani M, Keyhanfar F, Motevalian M, Mahmoudian M.Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.J Pharm Pharm Sci. 2010;13(1):1-10.
  4. Shaghaghi M, Manzoori JL, Jouyban A. Indirect spectrofluorimetric determination of omeprazole by its quenching effect on the fluorescence of Tb3+-1,10-phenanthroline complex in presence of bis (2-ethylhexyl) sulfosuccinate sodium in capsule formulations, DARU J Pharm Sci 2008;16(4):256-62.
  5. Ariane P, Rafael N, Bruno R, Marcos AS. Fábio S. Murakami Cruz Pereira ValenteSilva Development and validation of a RPHPLC method to quantify omeprazole in delayed release tablets. J Liquid Chromatography and Related Tecnologies 2007;30(1):113-21.
  6. Darwish KM, Salama I, Mostafa S, ElSadek M. RP-HPLC/pre-column derivatization for analysis of omeprazole, tinidazole, doxycycline and clarithromycin. JChromatogr Sci 2013;51(6):566-76.
  7. Raval PB, Puranik M, Wadher SJ, Yeole PG. A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form. Indian J Pharm Sci 2008;70(3):386-90.
  8. Berzas NJJ. Castañeda P. G Rodrguez D RM Method Berzas NJJ. Castañeda P. G Rodrguez D RM.  Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis. J Anal Chim Acta 533;2005:127-33.
  9. Jin-long Yan, Electrochemical behavior and the determination of omeprazole using glassy carbon electrode. J Sci Chem Pharm Bull (Tokyo) 2006;6(7):1625-7.
  10. Qaisi AM, Tutunji MF, Tutunji LF. Acid decomposition of omeprazole in the absence of thiol:a differential pulse polarographic study at the static mercury drop electrode . J Pharm Sci 2006;95(2):384-91.
  11. Mahmoud AM, Ahmed SA. A Validated High-Throughput Fluorometric Method for Determination of Omeprazole in Quality Control Laboratory via Charge Transfer Sensitized Fluorescence.J Fluoresc. 2016 Mar;26(2):521-9.
  12. V Gallardo 1, M López-Viota, J Sierra, M A Ruiz. Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations. Pharm Dev Technol 2009;14(5):516-23.2009;14(5):516-23.
  13. Bharathi DV, Hotha KK, Jagadeesh B, Chatki PK, Thriveni K, Mullangi R, Naidu  Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. A.Biomed Chromatogr. 2009 Jul;23(7):732-9.

Reference

  1. Karljikovic-Rajic K, Novovic D, Marinkovic V, Agbaba D.First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities..J Pharm Biomed Anal. 2003: 8(4-5);1019-27.
  2. Wahbi AA, Abdel-Razak O, Gazy AA, Mahgoub H, Moneeb MS. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations..J Pharm Biomed Anal. 2002:30(4);1133-42.
  3. Bhandage A, Bhosale A, Kasture A, Godse VP, Trop P, J. Extractive Spectrophotometric Determination of Omeprazole in Pharmaceutical. J Chem Pharm Bull (Tokyo) 2009:8(5);449-54
  4. Ashraf M. Mahmoud, New sensitive kinetic spectrophotometric methods for determination of omeprazole in dosage forms Int J Anal Chem, 2009: 1-11.
  5. Lotfy HM, Abdel-Monem Hagazy M. Comparative study of novel spectrophotometric methods manipulating ratio spectra:an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochimica acta Part A, Molecular and biomolecular spectroscopy 2012:96;259-70.
  6. Shakeel Ahmed, Santosh R. Karajgi, CC. Simpi, Savita sonawane, N.V.Kalyane. Visible spectrophotometric method for the estimation of losartan and omeprazole in single component pharmaceutical formulations. International Journal of PharmTech Research. 2009:1(4), 1247-1250.
  7. Mehdi Ansari, “Development and validation of kinetic spectrophotometric method for the determination of losartan potassium in pure and commercial tablets”, IJPT. 2004; 3: 21-25.
  8. Sashy C, Naidu P, murthy S, Spectrophotometric method for estimation of omeprazole, Indian journal pharm Sci, 2007; 69: 318-20 5. Muran Ozaltin & Aysegul Kocer, Determination of omeprazole in pharmaceuticals by derivative spectroscopy,journal of pharmaceutical and biomedical analysis, 1997;16(2): 337-342 6.
  9. Salama F, Abasaway. E, Validation of the spectrophometric determination of omeprazole & pantoprazole sodium via their metal chelates,journal of pharmaceutical & bio medical analysis, 2003; 33: 411-421.
  10. Abdel– Aziz M., Mayma.A, Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations, 2002; 30: 1133 – 1142.
  11. Sanker D.G,“Extractive spectrophotometric determination of losartan Potassium using acidic and basic dyes”, Indian drugs, 2003; 40: 724- 726. 3.
  12. Panel Abdel-Aziz, M Wahbi, Omayma Abdel-Razak, Azza A Gazy,             Hoda Mahgoub, Marwa S Moneeb. Spectrophotometric determination of omeprazole,lansoprazole and pantoprazole in pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis,2002: 30(4) 1133-1142.
  13. Harrizul Rivai, Rizqa Hasanah, Zikra Azizah Recent Development and Validation of Omeprazole Analysis Methods in Capsules with Absorbance Methods and Areas under Curves Methods with UV- Vis Spectrophotometry. Technological Innovation in Pharmaceutical Research. 2021: 3-35-47

 

  1. Nevin Erk, Analysis of binary mixture of losartan and hydrochlorothize by using high performance liquid chromatography, ratio derivative spectrophotometric and compecsation technique , J. Pharm. Biomed anal., 2001; 24: 603-611.
  2. El-Sherif ZA, Mohamed AO, ElBardicy MG, El-Tarras MF. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products. J Chem Pharm Bull (Tokyo) 2006;54(6):814-8.
  3. Noubarani M, Keyhanfar F, Motevalian M, Mahmoudian M.Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.J Pharm Pharm Sci. 2010;13(1):1-10.
  4. Shaghaghi M, Manzoori JL, Jouyban A. Indirect spectrofluorimetric determination of omeprazole by its quenching effect on the fluorescence of Tb3+-1,10-phenanthroline complex in presence of bis (2-ethylhexyl) sulfosuccinate sodium in capsule formulations, DARU J Pharm Sci 2008;16(4):256-62.
  5. Ariane P, Rafael N, Bruno R, Marcos AS. Fábio S. Murakami Cruz Pereira ValenteSilva Development and validation of a RPHPLC method to quantify omeprazole in delayed release tablets. J Liquid Chromatography and Related Tecnologies 2007;30(1):113-21.
  6. Darwish KM, Salama I, Mostafa S, ElSadek M. RP-HPLC/pre-column derivatization for analysis of omeprazole, tinidazole, doxycycline and clarithromycin. JChromatogr Sci 2013;51(6):566-76.
  7. Raval PB, Puranik M, Wadher SJ, Yeole PG. A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form. Indian J Pharm Sci 2008;70(3):386-90.
  8. Berzas NJJ. Castañeda P. G Rodrguez D RM Method Berzas NJJ. Castañeda P. G Rodrguez D RM.  Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis. J Anal Chim Acta 533;2005:127-33.
  9. Jin-long Yan, Electrochemical behavior and the determination of omeprazole using glassy carbon electrode. J Sci Chem Pharm Bull (Tokyo) 2006;6(7):1625-7.
  10. Qaisi AM, Tutunji MF, Tutunji LF. Acid decomposition of omeprazole in the absence of thiol:a differential pulse polarographic study at the static mercury drop electrode . J Pharm Sci 2006;95(2):384-91.
  11. Mahmoud AM, Ahmed SA. A Validated High-Throughput Fluorometric Method for Determination of Omeprazole in Quality Control Laboratory via Charge Transfer Sensitized Fluorescence.J Fluoresc. 2016 Mar;26(2):521-9.
  12. V Gallardo 1, M López-Viota, J Sierra, M A Ruiz. Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations. Pharm Dev Technol 2009;14(5):516-23.2009;14(5):516-23.
  13. Bharathi DV, Hotha KK, Jagadeesh B, Chatki PK, Thriveni K, Mullangi R, Naidu  Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study. A.Biomed Chromatogr. 2009 Jul;23(7):732-9.

Photo
K. Prabhavathi
Corresponding author

KVR government College for Women, Kurnool

Photo
K. Chandra Rekha
Co-author

KVR Government College for Women, Kurnool

K. Prabhavathi*, K. Chandra Rekha, Analytical Method Development for Assay of Omeprazole in Bulk and Pharmaceutical preparations, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 8, 2593-2598. https://doi.org/10.5281/zenodo.13220458

More related articles
Methotrexate Induced Pancytopenia In A Patient Wit...
Abdullah Ismail Bhoraniya, Asad Sayyed, Surekha Hoskeri, ...
Analytical Method Validation of Tablet Dosage Form...
Dr Anu Jindal, Simranjeet Singh, Muskan Sood, Rajmeet Singh, Satv...
Healing with Herbs: Exploring Herbal Medicine for Periodontal Disease Management...
Saurabh R. Thadani, saurabh Raghute , Bhoyar Samir, Dhule Damini, Trivedi Rashmi, Awandekar Nishant,...
Development Of Spanlastics: Nanovesicular Drug Delivery Of Oxiconazole Nitrate...
Krishnananda Kamath K., Vindhya V. S., Shripathy D., A. R. Shabaraya, ...
Biological Activities Of Ginseng And Its Application To Human Health...
Tushar Dewangan , Suraj Sahu, Suraj Patel, Miss Divyani Soni, Dr. Shruti Rathore, ...
Related Articles
Formulation and Characterization of an Advanced Mouth Dissolving Drug Delivery S...
Nikita M. Wakchaware, Akshay B. Ghanmode, Vanshika K. Sahu, Mayuri S. Pawar, Ashwini V. Aswar, Vaish...
A Review On Novel Excipients...
Vaibhav B. Gunjal, Darshan S. Sonawane, Samruddhi K. Ahire, Pranav K. Jadhav, Yashashri K. Deore, Sh...
Hypertrophic Pachymeningitis: A Literature Review...
Lekshmi R, Aparna Anil, Shaiju S. Dharan, Drishya L., ...
More related articles
Methotrexate Induced Pancytopenia In A Patient With Rheumatoid Arthritis And Pso...
Abdullah Ismail Bhoraniya, Asad Sayyed, Surekha Hoskeri, ...
Analytical Method Validation of Tablet Dosage Form of Lurasidone HCl...
Dr Anu Jindal, Simranjeet Singh, Muskan Sood, Rajmeet Singh, Satvinder Kaur, Jaswinder Singh, Shavet...
Methotrexate Induced Pancytopenia In A Patient With Rheumatoid Arthritis And Pso...
Abdullah Ismail Bhoraniya, Asad Sayyed, Surekha Hoskeri, ...
Analytical Method Validation of Tablet Dosage Form of Lurasidone HCl...
Dr Anu Jindal, Simranjeet Singh, Muskan Sood, Rajmeet Singh, Satvinder Kaur, Jaswinder Singh, Shavet...